BIOCRYST PHARMACEUTICALS INC (BCRX)

Sentiment-Signal

34,3

Bearisch

Composite Score (0–100)

Insider (25%)

Keine Insider-Käufe

Institutionell (22,5%)

51.4

1 neu, 0 erhöht, -1312582K $ netto

Aktivist (12,5%)

Kein 13D/13G

Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II clinical trial for complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitor that is in Phase I clinical trial to treat fibrodysplasia ossificans progressiva; and Galidesivir, a RNA dependent-RNA polymerase inhibitor, which is in Phase I clinical trial to treat various RNA viruses, including Marburg, Yellow Fever, Ebola, and Zika. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; Mundipharma International Holdings Limited; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

Unternehmen & Branche

Name	BIOCRYST PHARMACEUTICALS INC
Ticker	BCRX
CIK	0000882796
Boerse	US
Sektor	Healthcare
Industrie	Biotechnology
SIC	2836 · Biological Products, (No Diagnostic Substances)

Wertpapier & Kennzahlen

CUSIP	09058v103
ISIN	US09058V1035
Typ	Common Stock
Marktkapitalisierung	1,92 Mrd. USD
Beta	0,69
Dividendenrendite	0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Nettoergebnis	EPS	Aktiva	Eigenkapital
2025-12-31	10-K	263,861,000	1.21	514,158,000	-119,153,000
2025-09-30	10-Q	12,899,000	0.06	446,424,000	-387,889,000
2025-06-30	10-Q	5,085,000	0.02	457,188,000	-421,594,000
2025-03-31	10-Q	32,000	0.00	480,047,000	-451,927,000
2024-12-31	10-K	-88,881,000	-0.43	490,420,000	-475,934,000
2024-09-30	10-Q	-14,033,000	-0.07	491,254,000	-468,563,000
2024-06-30	10-Q	-12,674,000	-0.06	472,419,000	-475,606,000
2024-03-31	10-Q	-35,379,000	-0.17	467,892,000	-476,167,000
2023-12-31	10-K	-226,539,000	-1.18	516,960,000	-455,528,000
2023-09-30	10-Q	-36,149,000	-0.19	522,924,000	-410,986,000
2023-06-30	10-Q	-75,326,000	-0.40	529,885,000	-388,713,000
2023-03-31	10-Q	-53,333,000	-0.28	509,737,000	-328,287,000
2022-12-31	10-K	-247,116,000	-1.33	550,000,000	-294,597,000
2022-09-30	10-Q	-42,520,000	-0.23	558,594,000	-242,659,000
2022-06-30	10-Q	-58,859,000	-0.32	510,538,000	-213,232,000
2022-03-31	10-Q	-74,196,000	-0.40	527,720,000	-164,215,000
2021-12-31	10-K	-184,062,000	-1.03	588,151,000	-106,986,000
2021-09-30	10-Q	-58,801,000	-0.33	265,763,000	-147,044,000
2021-06-30	10-Q	-43,198,000	-0.24	277,284,000	-106,075,000
2021-03-31	10-Q	-64,284,000		284,431,000	-74,988,000

Fondsaktivität (Vorquartalsvergleich)

Fonds	Aktuell (Stk)	Veränderung (Stk)	Wert (USD)	Status	Δ
VANGUARD GROUP INC	22,273,375	22,273,375	173,732,325	Neu	+100,0%
BlackRock, Inc.	21,137,791	21,137,791	164,874,767	Neu	+100,0%
RA CAPITAL MANAGEMENT, L.P.	15,827,186	15,827,186	123,452,051	Neu	+100,0%
STATE STREET CORP	11,073,211	11,073,211	86,371,046	Neu	+100,0%
Kynam Capital Management, LP	9,366,526	9,366,526	73,058,903	Neu	+100,0%
JANUS HENDERSON GROUP PLC	7,404,386	7,404,386	57,791,233	Neu	+100,0%
UBS Group AG	5,271,914	5,271,914	41,120,929	Neu	+100,0%
GEODE CAPITAL MANAGEMENT, LLC	5,053,786	5,053,786	39,426,800	Neu	+100,0%
TWO SIGMA INVESTMENTS, LP	4,515,317	4,515,317	35,219,473	Neu	+100,0%
GOLDMAN SACHS GROUP INC	3,212,785	3,212,785	25,059,723	Neu	+100,0%
PERCEPTIVE ADVISORS LLC	3,162,529	3,162,529	24,667,726	Neu	+100,0%
Eversept Partners, LP	2,992,895	2,992,895	23,344,581	Neu	+100,0%
BAKER BROS. ADVISORS LP	2,822,727	2,822,727	22,017,271	Neu	+100,0%
BNP PARIBAS FINANCIAL MARKETS	2,542,714	2,542,714	19,833,169	Neu	+100,0%
Fisher Asset Management, LLC	2,467,567	2,467,567	19,247,022	Neu	+100,0%
Vestal Point Capital, LP	2,250,000	2,250,000	17,550,000	Neu	+100,0%
Qube Research & Technologies Ltd	2,164,162	2,164,162	16,880,464	Neu	+100,0%
RENAISSANCE TECHNOLOGIES LLC	2,128,821	2,128,821	16,604,804	Neu	+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	2,004,939	2,004,939	15,638,524	Neu	+100,0%
NORTHERN TRUST CORP	1,856,903	1,856,903	14,483,844	Neu	+100,0%
STIFEL FINANCIAL CORP	1,824,517	1,824,517	14,231,233	Neu	+100,0%
MORGAN STANLEY	1,745,563	1,745,563	13,615,396	Neu	+100,0%
Squarepoint Ops LLC	1,659,192	1,659,192	12,941,698	Neu	+100,0%
JANE STREET GROUP, LLC	1,547,457	1,547,457	12,070,164	Neu	+100,0%
BANK OF AMERICA CORP /DE/	1,535,557	1,535,557	11,977,344	Neu	+100,0%
CITADEL ADVISORS LLC	1,512,202	1,512,202	11,795,176	Neu	+100,0%
Nantahala Capital Management, LLC	1,356,377	1,356,377	10,579,741	Neu	+100,0%
Invesco Ltd.	1,354,897	1,354,897	10,568,197	Neu	+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	1,328,393	1,328,393	10,361,465	Neu	+100,0%
D. E. Shaw & Co., Inc.	1,247,466	1,247,466	9,730,235	Neu	+100,0%
DIMENSIONAL FUND ADVISORS LP	1,228,852	1,228,852	9,585,046	Neu	+100,0%
JACOBS LEVY EQUITY MANAGEMENT, INC	1,031,488	1,031,488	8,045,606	Neu	+100,0%
Hudson Bay Capital Management LP	1,017,374	1,017,374	7,935,517	Neu	+100,0%
Aberdeen Group plc	913,593	913,593	7,126,025	Neu	+100,0%
JPMORGAN CHASE & CO	843,370	843,370	6,578,286	Neu	+100,0%
SPHERA FUNDS MANAGEMENT LTD.	837,889	837,889	6,535,534	Neu	+100,0%
Susquehanna Portfolio Strategies, LLC	778,521	778,521	6,072,464	Neu	+100,0%
Pictet Asset Management Holding SA	740,510	740,510	5,711,948	Neu	+100,0%
BARCLAYS PLC	726,367	726,367	5,665,664	Neu	+100,0%
AQR CAPITAL MANAGEMENT LLC	704,291	704,291	5,493,470	Neu	+100,0%
PDT Partners, LLC	683,416	683,416	5,330,645	Neu	+100,0%
VOYA INVESTMENT MANAGEMENT LLC	625,490	625,490	4,878,822	Neu	+100,0%
FRANKLIN RESOURCES INC	570,189	570,189	4,447,474	Neu	+100,0%
FMR LLC	560,182	560,182	4,369,421	Neu	+100,0%
DEUTSCHE BANK AG\	491,086	491,086	3,830,471	Neu	+100,0%
GROUP ONE TRADING LLC	452,924	452,924	3,532,807	Neu	+100,0%
VOLORIDGE INVESTMENT MANAGEMENT, LLC	449,743	449,743	3,507,995	Neu	+100,0%
DAFNA Capital Management LLC	418,255	418,255	3,262,389	Neu	+100,0%
Man Group plc	407,850	407,850	3,181,230	Neu	+100,0%
Swiss National Bank	394,368	394,368	3,076,070	Neu	+100,0%

Insider-Transaktionen (12 Monate)

Datum	Insider	Rolle	Typ	Stückzahl	Kurs	Wert (USD)	Δ
2026-03-16	Barnes Alane P	Officer, Chief Legal Officer	Open Market Sale	-150,000	9.15	-1,372,500.00	-311,0%
2025-12-22	Barnes Alane P	Officer, Chief Legal Officer	Open Market Sale	-21,773	7.65	-166,563.45	-37,7%
2025-12-15	Barnes Alane P	Officer, Chief Legal Officer	Open Market Sale	-21,210	7.65	-162,256.50	-36,8%
2025-12-03	Barnes Alane P	Officer, Chief Legal Officer	Open Market Sale	-19,770	7.65	-151,240.50	-34,3%
2025-12-02	Barnes Alane P	Officer, Chief Legal Officer	Open Market Sale	-50,906	7.21	-367,215.52	-83,2%
2025-12-01	Barnes Alane P	Officer, Chief Legal Officer	Open Market Sale	-91,004	7.10	-646,510.62	-146,5%
2025-11-13	SANDERS MACHELLE	Director	Open Market Sale	-9,600	7.14	-68,544.00	-15,5%
2025-08-13	HEGGIE THERESA	Director	Open Market Sale	-70,000	8.51	-595,868.00	-135,0%

Top-Fondshalter

Stand: 31.03.2026

Fonds	Anteile	Wert (USD)	Anteil (%)
BENDER ROBERT & ASSOCIATES	23,710	225,719	100.00